These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22524708)

  • 1. Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis.
    D'Aversa TG; Eugenin EA; Lopez L; Berman JW
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):270-83. PubMed ID: 22524708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
    Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
    Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice.
    Oppenheim HA; Lucero J; Guyot AC; Herbert LM; McDonald JD; Mabondzo A; Lund AK
    Part Fibre Toxicol; 2013 Dec; 10():62. PubMed ID: 24344990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
    Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
    J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.
    Sonobe Y; Takeuchi H; Kataoka K; Li H; Jin S; Mimuro M; Hashizume Y; Sano Y; Kanda T; Mizuno T; Suzumura A
    J Biol Chem; 2009 Nov; 284(46):31834-42. PubMed ID: 19776017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier permeability towards small and large tracers in a mouse model of osmotic demyelination syndrome.
    Scalisi J; Balau B; Deneyer L; Bouchat J; Gilloteaux J; Nicaise C
    Neurosci Lett; 2021 Feb; 746():135665. PubMed ID: 33497716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.
    Dohgu S; Takata F; Matsumoto J; Kimura I; Yamauchi A; Kataoka Y
    Microvasc Res; 2019 Jul; 124():61-66. PubMed ID: 30885616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis.
    Rani A; Ergün S; Karnati S; Jha HC
    J Neurovirol; 2024 Feb; 30(1):22-38. PubMed ID: 38189894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.
    Kikuchi DS; Campos ACP; Qu H; Forrester SJ; Pagano RL; Lassègue B; Sadikot RT; Griendling KK; Hernandes MS
    J Neuroinflammation; 2019 Nov; 16(1):241. PubMed ID: 31779628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
    Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
    Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
    Front Immunol; 2022; 13():861486. PubMed ID: 35664003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burns Impair Blood-Brain Barrier and Mesenchymal Stem Cells Can Reverse the Process in Mice.
    Yang J; Ma K; Zhang C; Liu Y; Liang F; Hu W; Bian X; Yang S; Fu X
    Front Immunol; 2020; 11():578879. PubMed ID: 33240266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C; Förster C
    J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis.
    Shiryaev SA; Remacle AG; Savinov AY; Chernov AV; Cieplak P; Radichev IA; Williams R; Shiryaeva TN; Gawlik K; Postnova TI; Ratnikov BI; Eroshkin AM; Motamedchaboki K; Smith JW; Strongin AY
    J Biol Chem; 2009 Oct; 284(44):30615-26. PubMed ID: 19726693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage.
    Tang Y; Soroush F; Sun S; Liverani E; Langston JC; Yang Q; Kilpatrick LE; Kiani MF
    J Neuroinflammation; 2018 Nov; 15(1):309. PubMed ID: 30400800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
    Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
    PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.